GGrantIndex
Sort

166,118 grants matching stem cells

A novel immunotolerizing therapy for autoimmune vitiligo

$1,039,086
Kanneganti Murthy · Radikal Therapeutics, Inc. · R44 · FY2017 · AR

Development and Expansion of the Human Cerebral Cortex

$1,039,070
Arnold Kriegstein · University Of California, San Francisco · R35 · FY2024 · NS

Application of Expanded Myeloid Progenitors for Infection (Phase II)

$1,039,037
Ramkumar K Mandalam · Cellerant Therapeutics, Inc. · R44 · FY2006 · AI

Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease

$1,038,959
John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK

Applying Bioinformatics to Research in Immune, Muscle, and Bone Diseases

$1,038,805
Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIH · FY2017 · AR

Neurovascualar Regeneration

$1,038,788
Karen K Hirschi · Yale University · R01 · FY2014 · EB

CD19-Specific Central Memory T Cell Adoptive Immunotherapy for Non-Hodgkin Lymphoma

$1,038,189
Andrew A. Raubitschek · Beckman Research Institute/City Of Hope · P50 · FY2015 · CA

Genetically Engineered Mouse Models to Study RTK Function in Melanoma

$1,038,185
Glenn T. Merlino · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

The role of the intestinal microbiome in cancer immunotherapy

$1,038,040
Marcel R M Van Den Brink · Beckman Research Institute/City Of Hope · R35 · FY2025 · CA

ULTRASTABLE NONTOXIC RNA NANOPARTICLES FOR TARGETING TRIPLE-NEGATIVE BREAST CANCER STEM CELLS

$1,037,859
University Of Kentucky Research Foundation, The · · FY2015 · Department of the Army

In Vivo Cellular and Molecular Imaging Centers (ICMICs)

$1,037,769
Robert F Mattrey · University Of California, San Diego · P50 · FY2012 · CA

A planning project to pilot test and optimize dietary approaches to slow aging and design a long-term trial

$1,037,683
Corby K Martin · Lsu Pennington Biomedical Research Ctr · U01 · FY2022 · AG

ImmGen: a gene expression compendium for immune cells

$1,037,671
Christophe O Benoist · Harvard Medical School · R24 · FY2009 · AI

Neuroengineering a Robust Vocal Learning Phenotype in Mice as a Model for Treating Communication Disorders

$1,037,645
Erich D Jarvis · Rockefeller University · R01 · FY2019 · DC

A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy

$1,037,547
Yingbin Fu · Baylor College Of Medicine · U24 · FY2021 · EY

Regeneration of Clinically Relevant Orofacial Tissues in Pre-Clinical Models

$1,037,466
Jeremy J. Mao · Columbia University Health Sciences · RC2 · FY2010 · DE

Integrative Program in CNS Pathophysiology Research

$1,037,417
Ke Jian Liu · University Of New Mexico Health Scis Ctr · P30 · FY2013 · GM

Molecular Mechanisms of SOD1-linked ALS (P01)

$1,037,389
Joan S Valentine · University Of California Los Angeles · P01 · FY2011 · NS

Cell plasticity in the origin of gastric carcinogenesis

$1,037,059
Eunyoung Choi · Vanderbilt University Medical Center · R01 · FY2022 · CA

CORE CENTER OF EXCELLENCE IN MOLECULAR HEMATOLOGY

$1,037,000
Fred Hutchinson Cancer Research Center · P30 · FY2001 · DK

Receptor Mediated Erythropoietin Metabolic Response

$1,036,882
Constance Noguchi · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK

Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease

$1,036,834
Aaron D. Gitler · Stanford University · R35 · FY2021 · NS

Progenitor Regulation in Craniofacial Development and Regeneration

$1,036,816
Gage D Crump · University Of Southern California · R35 · FY2024 · DE

MyoRegulator: A non-invasive neuromodulation device for treatment of spasticity in stroke patients

$1,036,705
Nader Yaghoubi · Pathmaker Neurosystems, Inc. · U44 · FY2019 · NS

Selective targeting of high affinity alpha4 integrins as a safe treatment strategy for IBD

$1,036,641
Darren G Woodside · Aviara Pharmaceuticals, Inc. · R42 · FY2023 · DK